A Phase II/III Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis
Condition: Inclusion Body Myositis Intervention: Drug: ABC008 Sponsors: Abcuro, Inc.; Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials